Angka et al., 2022 - Google Patents
Perioperative arginine prevents metastases by accelerating natural killer cell recovery after surgeryAngka et al., 2022
View HTML- Document ID
- 2570439226500190834
- Author
- Angka L
- de Souza C
- Baxter K
- Khan S
- Market M
- Martel A
- Tai L
- Kennedy M
- Bell J
- Auer R
- Publication year
- Publication venue
- Molecular Therapy
External Links
Snippet
Profound natural killer (NK) cell suppression after cancer surgery is a main driver of metastases and recurrence, for which there is no clinically approved intervention available. Surgical stress is known to cause systemic postoperative changes that negatively modulate …
- 239000004475 Arginine 0 title abstract description 198
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Klysz et al. | Inosine induces stemness features in CAR-T cells and enhances potency | |
| Angka et al. | Perioperative arginine prevents metastases by accelerating natural killer cell recovery after surgery | |
| Takizawa et al. | Pathogen-induced TLR4-TRIF innate immune signaling in hematopoietic stem cells promotes proliferation but reduces competitive fitness | |
| Demaria et al. | Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variant | |
| Junker et al. | Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4 | |
| Ghelani et al. | Defining the threshold IL-2 signal required for induction of selective Treg cell responses using engineered IL-2 muteins | |
| Yao et al. | Accumulation of branched-chain amino acids reprograms glucose metabolism in CD8+ T cells with enhanced effector function and anti-tumor response | |
| Li et al. | Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell death | |
| Min et al. | Expression and regulation of complement receptors by human natural killer cells | |
| MX2010012214A (en) | Means for the treatment and/or prophylaxis of an autoimmune disease and for the formation of regulatory t-cells. | |
| Dong et al. | Lactoferrin-containing immunocomplex mediates antitumor effects by resetting tumor-associated macrophages to M1 phenotype | |
| Ni et al. | Up-regulation of gap junction in peripheral blood T lymphocytes contributes to the inflammatory response in essential hypertension | |
| Guan et al. | Staphylococcus aureus β-Hemolysin Up-Regulates the expression of IFN-γ by human CD56bright NK cells | |
| Zhang et al. | Amino acids and RagD potentiate mTORC1 activation in CD8+ T cells to confer antitumor immunity | |
| Vanichapol et al. | Secretory High‐Mobility Group Box 1 protein affects regulatory T cell differentiation in neuroblastoma microenvironment in vitro | |
| Raposo et al. | System A amino acid transporters regulate glutamine uptake and attenuate antibody‐mediated arthritis | |
| Mittmann et al. | Uncoupled biological and chronological aging of neutrophils in cancer promotes tumor progression | |
| Akuzum et al. | Context-dependent regulation of type17 immunity by microbiota at the intestinal barrier | |
| Franco et al. | Pediatric tolerogenic DCs expressing CD4 and immunoglobulin‐like transcript receptor (ILT)‐4 secrete IL‐10 in response to Fc and adenosine | |
| Flerin et al. | Impact of immunometabolism on cancer metastasis: a focus on T cells and macrophages | |
| Régnier et al. | FLT3L-dependent dendritic cells control tumor immunity by modulating Treg and NK cell homeostasis | |
| Aguiló et al. | Protein kinase C-θ is required for NK cell activation and in vivo control of tumor progression | |
| Viano et al. | Virtual memory CD8+ T cells: origin and beyond | |
| Koda et al. | CCR9 axis inhibition enhances hepatic migration of plasmacytoid DCs and protects against liver injury | |
| Müller et al. | Staphylococcus aureus induces tolerance in human monocytes accompanied with expression changes of cell surface markers |